Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J. David Endicott


  • Director at Orexigen Therapeutics Inc. (OREX), 2017-07-18
  • Director at Zeltiq Aesthetics Inc (ZLTQ), 2017-04-28
  • Pres., Hospira Medical Devices at Hospira Inc (HSP), 2015-09-03
  • Cvp And President, Agn Med at Allergan Inc (AGN), 2013-07-09
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AGN $92.33 1,840 Officer 20,352 2012-11-29 Filing
AGN $92.27 100 Officer 22,192 2012-11-29 Filing
AGN $92.43 52,560 Officer 20,352 2012-11-29 Filing
AGN $93.81 27,500 Officer 20,352 2012-05-07 Filing